These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33783545)

  • 1. Spinal Muscular Atrophy: Inheritance, Screening, and Counseling for the Obstetric Provider.
    Hopkins MK; Dugoff L; Kuller JA
    Obstet Gynecol Surv; 2021 Mar; 76(3):166-169. PubMed ID: 33783545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier Screening and Prenatal Diagnosis for Spinal Muscular Atrophy in 13,069 Chinese Pregnant Women.
    Zhang J; Wang Y; Ma D; Sun Y; Li Y; Yang P; Luo C; Jiang T; Hu P; Xu Z
    J Mol Diagn; 2020 Jun; 22(6):817-822. PubMed ID: 32205292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expert consensus over genetic counseling for carrier screening of Spinal muscular atrophy].
    Consensus Expert Group On Carrier Screening For Monogenic Disorders ; Genetic Counseling Group Of Medical Genetics Branch Of Chinese Medical Association ; Hu T; Guo J; Liu S; Lu Y; Chang Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jun; 41(6):661-668. PubMed ID: 38818549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study.
    Su YN; Hung CC; Lin SY; Chen FY; Chern JP; Tsai C; Chang TS; Yang CC; Li H; Ho HN; Lee CN
    PLoS One; 2011 Feb; 6(2):e17067. PubMed ID: 21364876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens.
    Sugarman EA; Nagan N; Zhu H; Akmaev VR; Zhou Z; Rohlfs EM; Flynn K; Hendrickson BC; Scholl T; Sirko-Osadsa DA; Allitto BA
    Eur J Hum Genet; 2012 Jan; 20(1):27-32. PubMed ID: 21811307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for Cystic Fibrosis Carrier Screening in the Prenatal/Preconception Period.
    Hopkins MK; Dugoff L; Kuller JA
    Obstet Gynecol Surv; 2022 Oct; 77(10):606-610. PubMed ID: 36242530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests.
    Archibald AD; Smith MJ; Burgess T; Scarff KL; Elliott J; Hunt CE; McDonald Z; Barns-Jenkins C; Holt C; Sandoval K; Siva Kumar V; Ward L; Allen EC; Collis SV; Cowie S; Francis D; Delatycki MB; Yiu EM; Massie RJ; Pertile MD; du Sart D; Bruno D; Amor DJ
    Genet Med; 2018 Apr; 20(5):513-523. PubMed ID: 29261177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier testing for spinal muscular atrophy.
    Gitlin JM; Fischbeck K; Crawford TO; Cwik V; Fleischman A; Gonye K; Heine D; Hobby K; Kaufmann P; Keiles S; MacKenzie A; Musci T; Prior T; Lloyd-Puryear M; Sugarman EA; Terry SF; Urv T; Wang C; Watson M; Yaron Y; Frosst P; Howell RR
    Genet Med; 2010 Oct; 12(10):621-2. PubMed ID: 20808230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal Carrier Screening for Spinal Muscular Atrophy.
    Wood SL; Brewer F; Ellison R; Biggio JR; Edwards RK
    Am J Perinatol; 2016 Oct; 33(12):1211-7. PubMed ID: 27611803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving approaches to prenatal genetic counseling for Spinal Muscular Atrophy in the new treatment era.
    Zettler B; Estrella E; Liaquat K; Lichten L
    J Genet Couns; 2022 Jun; 31(3):803-814. PubMed ID: 35037741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current attitudes toward carrier screening for spinal muscular atrophy among pregnant women in Eastern China.
    Li Y; Wang L; Tan J; Huang M; Wang Y; Shao B; Lv J; Zhang J
    J Genet Couns; 2023 Aug; 32(4):823-832. PubMed ID: 36775845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission ratio distortion in the spinal muscular atrophy locus: data from 314 prenatal tests.
    Botta A; Tacconelli A; Bagni I; Giardina E; Bonifazi E; Pietropolli A; Clementi M; Novelli G
    Neurology; 2005 Nov; 65(10):1631-5. PubMed ID: 16301493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening for spinal muscular atrophy mutation carriers among 4931 pregnant women from Liuzhou region of Guangxi].
    Tan J; Zhang X; Wang Y; Luo S; Yang F; Liu B; Cai R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Aug; 35(4):467-470. PubMed ID: 30098235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of experiential knowledge within attitudes towards genetic carrier screening: A comparison of people with and without experience of spinal muscular atrophy.
    Boardman FK; Young PJ; Warren O; Griffiths FE
    Health Expect; 2018 Feb; 21(1):201-211. PubMed ID: 28703871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Result of carrier screening for spinal muscular atrophy among 3049 reproductive-age individuals from Yunnan region].
    Zhang Y; Wang L; He J; Guo J; Jin C; Tang X; Zhang J; Chen H; Zhang J; Su J; Zhu B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Apr; 37(4):384-388. PubMed ID: 32219818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal muscular atrophy carriers with two SMN1 copies.
    Ar Rochmah M; Awano H; Awaya T; Harahap NIF; Morisada N; Bouike Y; Saito T; Kubo Y; Saito K; Lai PS; Morioka I; Iijima K; Nishio H; Shinohara M
    Brain Dev; 2017 Nov; 39(10):851-860. PubMed ID: 28676237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population carrier screening for spinal muscular atrophy a position statement of the association for molecular pathology.
    Muralidharan K; Wilson RB; Ogino S; Nagan N; Curtis C; Schrijver I
    J Mol Diagn; 2011 Jan; 13(1):3-6. PubMed ID: 21227388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of Spinal Muscular Atrophy (SMA) for Prenatal and Pediatric Genetic Counselors.
    Carré A; Empey C
    J Genet Couns; 2016 Feb; 25(1):32-43. PubMed ID: 26250347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded Carrier Screening.
    Gregg AR
    Obstet Gynecol Clin North Am; 2018 Mar; 45(1):103-112. PubMed ID: 29428278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.